SPGI vs XOMAP · P/E 27, rev $15.34B vs P/E 25, rev $28.5M
S&P Global Inc (SPGI) versus XOMA Royalty Corporation (XOMAP) — a side-by-side from cached financials, not a winner call.
S&P Global Inc (SPGI) is a financial data & stock exchanges company listed on NYSE.
XOMA Royalty Corporation (XOMAP) is a biotechnology company listed on NASDAQ.
Latest reported SPGI revenue for 2025-12-31 was $15.34B. Net income was $4.47B. Revenue was up 7.9% from 2024-12-31 to 2025-12-31. SPGI currently screens at market cap $127.50B and trailing P/E 27.2.
Latest reported XOMAP revenue for 2024-12-31 was $28.5M. Net income was -$13.8M. Revenue was up 498.7% from 2023-12-31 to 2024-12-31. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
SPGI currently screens at market cap $127.50B and trailing P/E 27.2. XOMAP currently screens at market cap $0 and trailing P/E 25.4.
Not investment advice. Open the SPGI and XOMAP stock pages for the full models.
Not investment advice.